AutoSCT after remission shows no benefit to remission duration, survival in double-hit lymphoma in latest @JCO_ASCO … https://t.co/fedfWpEE1p

AutoSCT after remission shows no benefit to remission duration, survival in double-hit lymphoma in latest @JCO_ASCO … https://t.co/fedfWpEE1p

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/864124906887413760
via IFTTT